ESC Premium Access

SGLT2 inhibitors: uncovering the mechanisms of cardiovascular risk reduction

Topic: Pathophysiology and Mechanisms
Supported by an unrestricted educational grant from AstraZeneca

Congress Presentation

About the speaker

Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)
28 presentations
1 follower

4 more presentations in this session

The hidden burden of heart failure

Speaker: Professor F. Ruschitzka (Zurich, CH)


The clinical impact of SGLT2 inhibitor cardiovascular outcomes trials

Speaker: Doctor M. Bonaca (Aurora, US)


Lighting the way to the future of heart failure management

Speaker: Doctor M. Kosiborod (Kansas City, US)


Questions and answers

Speaker: Professor F. Ruschitzka (Zurich, CH) Doctor M. Bonaca (Aurora, US) Professor S. Verma (Toronto, CA) Doctor M. Kosiborod (Kansas City, US)


Access the full session

Spotlight on the effects of SGLT2 inhibition in heart failure (EBAC accredited)

Speakers: Professor S. Verma, Professor F. Ruschitzka, Doctor M. Bonaca, Doctor M. Kosiborod, Professor F. Ruschitzka...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb